PDC-1421 Capsule

DRUG4 trials

Sponsors

BioLite, Inc.

Conditions

Attention-Deficit Hyperactivity Disorder (ADHD)Major Depressive Disorder

Phase 1

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Not yet recruitingNCT03833206

BioLite, Inc.Major Depressive Disorder

Start: 2027-01-15End: 2028-02-28Target: 12Updated: 2026-04-20

Phase 2

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

CompletedNCT02395978

BioLite, Inc.Major Depressive Disorder

Start: 2015-04-10End: 2019-03-18Updated: 2021-07-22

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

CompletedNCT02699086

BioLite, Inc.Attention-Deficit Hyperactivity Disorder (ADHD)

Start: 2019-12-01End: 2020-07-15Updated: 2021-12-01

PDC-1421 Treatment in Adult Patients With ADHD

CompletedNCT05202327

BioLite, Inc.Attention-Deficit Hyperactivity Disorder (ADHD)

Start: 2022-04-07End: 2024-04-08Updated: 2026-05-06